Heparin, Low-Molecular-Weight

"Heparin, Low-Molecular-Weight" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.

Descriptor ID	D006495
MeSH Number(s)	D09.698.373.400.300
Concept/Terms	Heparin, Low-Molecular-Weight Heparin, Low-Molecular-Weight Heparin, Low Molecular Weight LMWH Low Molecular Weight Heparin Low-Molecular-Weight Heparin

Below are MeSH descriptors whose meaning is more general than "Heparin, Low-Molecular-Weight".

Chemicals and Drugs [D]
Carbohydrates [D09]
Polysaccharides [D09.698]
Glycosaminoglycans [D09.698.373]
Heparin [D09.698.373.400]
Heparin, Low-Molecular-Weight [D09.698.373.400.300]

Below are MeSH descriptors whose meaning is related to "Heparin, Low-Molecular-Weight".

Below are MeSH descriptors whose meaning is more specific than "Heparin, Low-Molecular-Weight".

Heparin, Low-Molecular-Weight
Dalteparin
Enoxaparin
Nadroparin

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heparin, Low-Molecular-Weight" by people in this website by year, and whether "Heparin, Low-Molecular-Weight" was a major or minor topic of these publications.

Bar chart showing 20 publications over 14 distinct years, with a maximum of 3 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	0	1	1
2005	1	0	1
2006	1	0	1
2007	1	2	3
2008	0	1	1
2009	0	1	1
2010	1	1	2
2012	1	0	1
2013	0	1	1
2014	2	0	2
2020	0	2	2
2024	1	1	2
2025	0	1	1

Below are the most recent publications written about "Heparin, Low-Molecular-Weight" by people in Profiles.

Stubblefield WB, Helderman R, Strokes N, Greineder CF, Barnes GD, Vinson DR, Westafer LM. Factors in Initial Anticoagulation Choice in Hospitalized Patients With Pulmonary Embolism. JAMA Netw Open. 2025 Jan 02; 8(1):e2452877.

View in: PubMed
Shu L, Jack N, de Havenon A, Goldstein ED, Khan F, Nguyen TN, Henninger N, Siegler JE, Stretz C, Perelstein E, Kala N, Rana M, Furie KL, Douketis JD, Yaghi S. Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial. J Stroke Cerebrovasc Dis. 2024 Sep; 33(9):107839.

View in: PubMed
Westafer LM, Presti T, Shieh MS, Pekow PS, Barnes GD, Kapoor A, Lindenauer PK. Trends in Initial Anticoagulation Among US Patients Hospitalized With Acute Pulmonary Embolism 2011-2020. Ann Emerg Med. 2024 Nov; 84(5):518-529.

View in: PubMed
Maatman TK, McGuire SP, Lewellen KA, McGreevy KA, Ceppa EP, House MG, Nakeeb A, Nguyen TK, Schmidt CM, Zyromski NJ. Prospective Analysis of the Mechanisms Underlying Ineffective Deep Vein Thrombosis Prophylaxis in Necrotizing Pancreatitis. J Am Coll Surg. 2021 01; 232(1):91-100.

View in: PubMed
Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Stroke. 2020 09; 51(9):2724-2732.

View in: PubMed
Kapoor A, Ellis A, Shaffer N, Gurwitz J, Chandramohan A, Saulino J, Ishak A, Okubanjo T, Michota F, Hylek E, Trikalinos TA. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J Thromb Haemost. 2017 02; 15(2):284-294.

View in: PubMed
Huang W, Anderson FA, Rushton-Smith SK, Cohen AT. Impact of thromboprophylaxis across the US acute care setting. PLoS One. 2015; 10(3):e0121429.

View in: PubMed
Alyahya R, Sudha T, Racz M, Stain SC, Mousa SA. Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models. Int J Oncol. 2015 Mar; 46(3):1225-31.

View in: PubMed
Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, Yung M, Truemper E, Qin L, Li S, Marohn K, Randolph AG. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med. 2014 May; 42(5):1232-40.

View in: PubMed
Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R, Shermock K, Chelladurai Y, Singh S, Segal JB. Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. JAMA Surg. 2013 Jul; 148(7):675-86.

View in: PubMed

People

Explore

Similar Concepts

Top Journals